Rns - asthma medicine research with Oxford uni10 Aug 2021 08:24
Very interesting rns this morning.
‘The three-year project will focus on identifying novel drug targets for patients with severe forms of asthma that do not respond to the current standard of care and where pre-existing treatments such as corticosteroids and biologics are less effective.’
Highlight for me is
‘ The IP in any novel drug target identified by this research will be owned by Sensyne Health with a royalty payment back to Oxford University and the Oxford University Hospitals NHS Foundation’
It’s no guarantee that we will find a drug but this will be a real test to prove if our AI really is the product we are hoping it is.
If we find a drug that can combat or even cure asthma and own the IP then surely that is going to lead to a rather nice bump up of the share price or potential takeover.
Let the good times roll